NCT06474169Recruiting
Assessment of T-cell Response and In-vitro Proof-of-concept of T-cell Engineering in Chronic ESKD Patients.
Assessment of T-cell Response and In-vitro Proof-of-concept of T-cell Engineering in Chronic End-stage Kidney Disease Patients.
Source: ClinicalTrials.gov · Last updated 25 Jun 2026
Brief summary (registry, in English)
This is a comparative, prospective, non-interventional study to evaluate immune response in patients with chronic kidney disease. The primary objective is to define immunodeficiency (phenotype and function of T cells) in patients with end-stage kidney disease. The second objective is to provide an in-vitro proof-of-concept of T-cell engineering in the context of end-stage kidney disease. The study population was patients with chronic kidney disease.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 10 Jun 2024
- Start date
- 27 Nov 2024
- Primary completion date
- Dec 2026
- Lead sponsor
- Centre Hospitalier Régional d'Orléans
- Diseases
- Chronic kidney disease
- NCT number
- NCT06474169
What you commit to
- Study type: Observational
- Planned participants: 100
- From 27 Nov 2024 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior organ transplantation (including bone marrow transplantation)
- Previous treatment with immunosuppressive agents (such as Rituximab, Eculizumab, Tacrolimus or Ciclosporin, Cellcept or Imurel) within 2 years prior to inclusion
Other illness
- Chronic progressive infections
Other
- Participant under guardianship, curatorship or deprived of liberty
- Pregnant or breastfeeding women
Who the study is looking for
- Male or female ≥ 18 years
- Informed participants who did not object to participating in the study
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Center Hospitalier Universitaire d'Orléans Coordinator of this site? Confirm its status | Orléans | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.